9996 — Peijia Medical Share Price
0.000.00%
Last trade - 00:00- HK$3.38bn
- HK$2.91bn
- CNY615.48m
Growth & Value
| 12m Forecast Rolling | Industry | Market | |
|---|---|---|---|
| PE Ratio (f) | n/a | ||
| PEG Ratio (f) | n/a | ||
| EPS Growth (f) | n/a | ||
| Dividend Yield (f) | n/a | ||
| Valuation (ttm) | Industry | Market | |
|---|---|---|---|
| Price to Book Value | 1.68 | ||
| Price to Tang. Book | 2.48 | ||
| Price to Free Cashflow | n/a | ||
| Price to Sales | 5.52 | ||
| EV to EBITDA | n/a | ||
Shareholder Activity
| Type | Buy / Hold / Sell |
|---|---|
| Institutions | |
| Directors | |
| Community |
Guru Screens
Quality
| Name | Industry | Market | |
|---|---|---|---|
| Return on Capital | -10.66% | ||
| Return on Equity | -10.53% | ||
| Operating Margin | -38.89% | ||
Financial Summary
| Year End 31st Dec | Unit | 2020 | 2021 | 2022 | 2023 | 2024 | 2025E | 2026E | CAGR / Avg |
|---|---|---|---|---|---|---|---|---|---|
| Total Revenue | CNYm | 38.66 | 136.53 | 250.83 | 441.13 | 615.48 | 800.15 | 990.51 | 101.13% |
| Operating Profit | m | ||||||||
| Net Profit | m | ||||||||
| EPS Reported | |||||||||
| Diluted Normalised EPS | |||||||||
| EPS Growth | % | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
| PE Ratio | x | ||||||||
| PEG | |||||||||
| Profitability | |||||||||
| Operating Margin | % | ||||||||
| ROA | % | ||||||||
| ROCE | % | ||||||||
| ROE | % | ||||||||
| Cashflow | |||||||||
| Op. Cashflow ps | |||||||||
| Capex ps | |||||||||
| Free Cashflow ps | |||||||||
| Dividends | |||||||||
| Dividend ps | |||||||||
| Dividend Growth | % | ||||||||
| Dividend Yield | % | ||||||||
| Dividend Cover | x | ||||||||
| Balance Sheet | |||||||||
| Cash etc | m | ||||||||
| Working Capital | m | ||||||||
| NFA | m | ||||||||
| Net Debt | m | ||||||||
| Book Value | m | ||||||||
| Diluted Weighted Average Shares | m | ||||||||
| Book Value ps | |||||||||
Other Ratios
| Leverage (ttm) | Total | - Intang | + Pension |
|---|---|---|---|
| Gross Gearing | |||
| Net Gearing | |||
| Cash / Assets |
| Liquidity (ttm) | |
|---|---|
| Curr. Ratio | |
| Quick Ratio | |
| Interest Cov. | |
| Efficiency (ttm) | |
|---|---|
| Asset Turnover | |
| Recs Turnover | |
| Stock Turnover | |
Recent History
| Latest interim period vs. prior period | Industry | Market | |
|---|---|---|---|
| Sales Growth | |||
| EPS Growth | |||
| 3yr Compound Annual Growth Rate | Industry | Market | |
|---|---|---|---|
| Sales CAGR | |||
| EPS CAGR | |||
| DPS CAGR | |||
Profile Summary
Peijia Medical Ltd is an investment holding company principally engaged in the provision of interventional procedural medical device. The Company primarily operates its businesses through two segments, Transcatheter Valve Therapeutic Business segment and Neurointerventional Business segment. Transcatheter Valve Therapeutic Business segment is mainly engaged in the business of research and development, manufacturing and sales of transcatheter valve therapeutic medical devices. Neurointerventional Business segment is mainly involved in the business of research and development, manufacturing and sales of neurointerventional procedural medical devices. The Company’s products include commercialized products such as TaurusOne and TaurusElite. The Company mainly conducts its businesses in the domestic market.
Directors
- Yi Zhang CHM (53)
- Leo Tsai CFO (41)
- Kongrong Pan COO (63)
- Jian Fong Tan CTO (46)
- Xiaoli Shi VPR (36)
- Chen Wang GMG (46)
- Hong Ye EDR (49)
- Ping Ye Zhang EDR (53)
- Xiaoxiao Zhuang DSL (39)
- Hongpeng Wang DMK (41)
- Pui Chun Suen SEC (42)
- Fei Chen NED (41)
- Jifeng Guan NED (51)
- Jun Yang NED (40)
- Zhiyun Yu NED (42)
- Stephen Oesterle NID (70)
- Robert Parks NID (77)
- Huacheng Wei NID (61)
- Wai Ming Yip NID (56)
- Last Annual
- December 31st, 2024
- Last Interim
- December 31st, 2024
- Incorporated
- May 30th, 2012
- Public Since
- May 15th, 2020
- No. of Employees
- 1,047
- Sector
- Healthcare Equipment & Supplies
- Industry
- Healthcare
- Exchange
- Stock Exchange of Hong Kong Limited
- Shares in Issue
- 669,006,908
- Address
- 8 Zhongtian Street, SUZHOU
- Web
- https://www.peijiamedical.com/
- Phone
- Auditors
- PricewaterhouseCoopers
Upcoming Events for 9996
Similar to 9996
Acotec Scientific Holdings
Stock Exchange of Hong Kong Limited
Beijing Airdoc Technology Co
Stock Exchange of Hong Kong Limited
AK Medical Holdings
Stock Exchange of Hong Kong Limited
AMCO United Holding
Stock Exchange of Hong Kong Limited
Angelalign Technology
Stock Exchange of Hong Kong Limited
FAQ
What is the Peijia Medical share price?
As of Today at 22:35 UTC, shares in Peijia Medical are trading at HK$5.41. This share price information is delayed by 15 minutes.
How has the Peijia Medical share price performed this year?
Shares in Peijia Medical last closed at HK$5.41 and the price had moved by +47.81% over the past 365 days. In terms of relative price strength the Peijia Medical share price has outperformed the FTSE Developed Asia Pacific Index by +49.5% over the past year.
What are the analyst and broker recommendations for Peijia Medical?
The overall consensus recommendation for Peijia Medical is Buy. You can view the full broker recommendation list by unlocking its StockReport.
Find out moreWhat is the Peijia Medical dividend yield?
Peijia Medical does not currently pay a dividend.
Does Peijia Medical pay a dividend?
Peijia Medical does not currently pay a dividend.
When does Peijia Medical next pay dividends?
Peijia Medical does not currently pay a dividend.
How do I buy Peijia Medical shares?
To buy shares in Peijia Medical you'll need a share-dealing account with an online or offline stock broker. Once you have opened your account and transferred funds into it, you'll be able to search and select shares to buy and sell. You can use Stockopedia’s share research software to help you find the the kinds of shares that suit your investment strategy and objectives.
What is the market cap of Peijia Medical?
As of the previous close price of HK$5.41, shares in Peijia Medical had a market capitalisation of HK$3.38bn.
Where are Peijia Medical shares listed?
Here are the trading details for Peijia Medical:
- Country of listing: Hong Kong
- Exchange: HKG
- Ticker Symbol: 9996
What kind of share is Peijia Medical?
Based on an overall assessment of its quality, value and momentum Peijia Medical is currently classified as a Momentum Trap. The classification is based on a composite score that examines a wide range of fundamental and technical measures. Stock are classified on the the following spectrum: Super Stocks, High Flyers, Contrarians, Turnarounds, Neutral, Value Traps, Momentum Traps, Falling Stars, and Sucker Stocks. For more information, learn about our StockRank Styles.
Is there a Peijia Medical share price forecast for 2025?
The analyst consensus target price for shares in Peijia Medical is HK$6.49. That is 19.93% above the last closing price of HK$5.41.
Analysts covering Peijia Medical currently have a consensus Earnings Per Share (EPS) forecast of -CNY0.13 for the next financial year.
Find out moreWhat is the trend in the Peijia Medical share price?
An important predictor of whether a stock price will go up is its track record of momentum. Price trends tend to persist, so it's worth looking at them when it comes to a share like Peijia Medical. Over the past six months, its share price has outperformed the FTSE Developed Asia Pacific Index by +38.8%.
As of the last closing price of HK$5.41, shares in Peijia Medical were trading +45.92% higher than their 200 day moving average. You can read more about the power of momentum in assessing share price movements on Stockopedia.
What is the Peijia Medical PE Ratio?
The Peijia Medical PE ratio based on its reported earnings over the past 12 months is null. The shares last closed at HK$5.41.
The PE ratio (or price-to-earnings ratio) is the one of the most popular valuation measures used by stock market investors. It is calculated by dividing a company's price per share by its earnings per share.
The PE ratio can be seen as being expressed in years, in the sense that it shows the number of years of earnings which would be required to pay back the purchase price, ignoring inflation. So in general terms, the higher the PE, the more expensive the stock is.
Who are the key directors of Peijia Medical?
Peijia Medical's management team is headed by:
- Yi Zhang - CHM
- Leo Tsai - CFO
- Kongrong Pan - COO
- Jian Fong Tan - CTO
- Xiaoli Shi - VPR
- Chen Wang - GMG
- Hong Ye - EDR
- Ping Ye Zhang - EDR
- Xiaoxiao Zhuang - DSL
- Hongpeng Wang - DMK
- Pui Chun Suen - SEC
- Fei Chen - NED
- Jifeng Guan - NED
- Jun Yang - NED
- Zhiyun Yu - NED
- Stephen Oesterle - NID
- Robert Parks - NID
- Huacheng Wei - NID
- Wai Ming Yip - NID